CDT Equity, Inc. (CDT)
1.12
+0.11
(+10.89%)
USD |
NASDAQ |
Feb 06, 16:00
1.06
-0.06
(-5.36%)
After-Hours: 20:00
CDT Equity SG&A Expense (TTM) : 14.67M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| LENZ Therapeutics, Inc. | 60.86M |
| Liminatus Pharma, Inc. | 2.342M |
| Oruka Therapeutics, Inc. | 19.44M |
| Maze Therapeutics, Inc. | 31.47M |
| MapLight Therapeutics, Inc. | 8.221M |